Slabs which it suffers from the beginning of the month of December (see our March 16 editions of the latter)..

Finally, the European pharmacovigilance (monitoring and recording of side effects of vaccines on a European level) was not observed following vaccination of 36 million people on the continent, increasing cases of multiple sclerosis. In total, the European Medicines Agency (EMA), only 4 cases were reported since the beginning of the vaccination campaign to date. This figure is even lower than the number of cases reported in the normal period, out vaccination campaigns. As a result, the BMA concludes that there is no suspicion that immunization against the new virus increases the risk of multiple sclerosis or cause an aggravation of symptoms among sufferers.

The vaccine against influenza A is based on a virus kills and does not at all the same immune response. The activation is much lower than during an attack the virus itself. During a virus infection, the entire body begins to react. While in a vaccine, it is only close to where the lymph nodes of injection rally.

Out of immunization period, the incidence in the general population of this syndrome is 1 to 1.8 per 100,000 persons per year. For a period of six weeks following vaccination, we could expect to save between 49 and 80 new cases. The European Medicines Agency (EMA) has 49 lists, a figure in the standard. In our society, about 5% of the adult population suffer from problems of self-immunity. It is forcing people in whom the disease is triggered just before or after vaccination. This does not mean that there is a link.